Advanced BioMedical Technologies, Inc. ABMT
OTC PK
| 07/31/2021 | 04/30/2021 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -51.72% | -43.40% | |||
| Total Receivables | 34.87% | 46.15% | |||
| Inventory | 134.83% | 146.51% | |||
| Prepaid Expenses | -- | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 87.19% | 95.52% | |||
|
|
|||||
| Total Current Assets | 87.19% | 95.52% | |||
| Net Property, Plant & Equipment | 1.18% | -2.61% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 40.80% | 37.01% | |||
|
|
|||||
| Total Accounts Payable | -- | -- | |||
| Total Accrued Expenses | -- | -- | |||
| Short-term Debt | 6.69% | 4.76% | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -69.05% | -66.19% | |||
| Total Finance Division Other Current Liabilities | -17.20% | 114.06% | |||
| Total Other Current Liabilities | -17.20% | 114.06% | |||
| Total Current Liabilities | 18.09% | 19.54% | |||
|
|
|||||
| Total Current Liabilities | 18.09% | 19.54% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | 6.69% | 4.76% | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 17.93% | 19.32% | |||
|
|
|||||
| Common Stock & APIC | 1.91% | 1.89% | |||
| Retained Earnings | -7.48% | -7.71% | |||
| Treasury Stock & Other | -170.61% | -151.41% | |||
| Total Common Equity | -17.01% | -18.59% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -17.01% | -18.59% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -17.01% | -18.59% | |||
|
|
|||||